369 related articles for article (PubMed ID: 12640679)
1. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
2. Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages.
Kuniyasu H; Yano S; Sasaki T; Sasahira T; Sone S; Ohmori H
Am J Pathol; 2005 Mar; 166(3):751-60. PubMed ID: 15743787
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
Kuniyasu H; Chihara Y; Takahashi T
Oncol Rep; 2003; 10(2):445-8. PubMed ID: 12579287
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
Tafani M; Schito L; Pellegrini L; Villanova L; Marfe G; Anwar T; Rosa R; Indelicato M; Fini M; Pucci B; Russo MA
Carcinogenesis; 2011 Aug; 32(8):1167-75. PubMed ID: 21642357
[TBL] [Abstract][Full Text] [Related]
7. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
[TBL] [Abstract][Full Text] [Related]
8. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W
J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367
[TBL] [Abstract][Full Text] [Related]
9. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
11. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.
Bhawal UK; Ozaki Y; Nishimura M; Sugiyama M; Sasahira T; Nomura Y; Sato F; Fujimoto K; Sasaki N; Ikeda MA; Tsuji K; Kuniyasu H; Kato Y
Oncology; 2005; 69(3):246-55. PubMed ID: 16127291
[TBL] [Abstract][Full Text] [Related]
12. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
[TBL] [Abstract][Full Text] [Related]
13. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
[TBL] [Abstract][Full Text] [Related]
14. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.
Riuzzi F; Sorci G; Donato R
Am J Pathol; 2007 Sep; 171(3):947-61. PubMed ID: 17640970
[TBL] [Abstract][Full Text] [Related]
15. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas.
Sasahira T; Akama Y; Fujii K; Kuniyasu H
Virchows Arch; 2005 Apr; 446(4):411-5. PubMed ID: 15789216
[TBL] [Abstract][Full Text] [Related]
16. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
Kuniyasu H; Chihara Y; Kondo H; Ohmori H; Ukai R
Oncol Rep; 2003; 10(6):1863-8. PubMed ID: 14534709
[TBL] [Abstract][Full Text] [Related]
17. N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth.
Srikrishna G; Huttunen HJ; Johansson L; Weigle B; Yamaguchi Y; Rauvala H; Freeze HH
J Neurochem; 2002 Mar; 80(6):998-1008. PubMed ID: 11953450
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.
Huttunen HJ; Fages C; Kuja-Panula J; Ridley AJ; Rauvala H
Cancer Res; 2002 Aug; 62(16):4805-11. PubMed ID: 12183440
[TBL] [Abstract][Full Text] [Related]
19. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site.
Ishihara K; Tsutsumi K; Kawane S; Nakajima M; Kasaoka T
FEBS Lett; 2003 Aug; 550(1-3):107-13. PubMed ID: 12935895
[TBL] [Abstract][Full Text] [Related]
20. High-Mobility Group Box 1 Mediates Fibroblast Activity via RAGE-MAPK and NF-κB Signaling in Keloid Scar Formation.
Kim J; Park JC; Lee MH; Yang CE; Lee JH; Lee WJ
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]